• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛋白磷酸酶2A和2B对阿尔茨海默病成对螺旋丝的去磷酸化作用

Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.

作者信息

Wang J Z, Gong C X, Zaidi T, Grundke-Iqbal I, Iqbal K

机构信息

New York State Institute for Basic Research in Developmental Disabilities, Staten Island 10314.

出版信息

J Biol Chem. 1995 Mar 3;270(9):4854-60. doi: 10.1074/jbc.270.9.4854.

DOI:10.1074/jbc.270.9.4854
PMID:7876258
Abstract

Microtubule-associated protein tau is abnormally hyperphosphorylated in the brain of patients with Alzheimer disease and in this form is the major protein subunit of the paired helical filaments (PHF), the most prominent lesion of the disease. In this study the dephosphorylation of sparingly soluble PHF, PHF II-tau by brain protein phosphatase (PP)-2A1 and PP-2B, and the resulting biochemical, biological, and structural alterations were investigated. Both of the phosphatases dephosphorylated PHF II-tau at the sites of Ser-199/Ser-202 and partially dephosphorylated it at Ser-396/Ser-404; in addition, PHF II-tau was dephosphorylated at Ser-46 by PP-2A1 and Ser-235 by PP-2B. The relative electrophoretic mobility of PHF II-tau increased after dephosphorylation by either enzyme. Divalent cations, manganese, and magnesium increased the activities of PP-2A1 and PP-2B toward PHF II-tau. Dephosphorylation both by PP-2B and PP-2A1 decreased the resistance of PHF II-tau to proteolysis by the brain calcium-activated neutral proteases (CANP). The ability of PHF II-tau to promote the in vitro microtubule assembly was restored after dephosphorylation by PP-2A1 and PP-2B. Microtubules assembled by the dephosphorylated PHF II-tau were structurally identical to those assembled by bovine tau used as a control. The dephosphorylation both by PP-2A1 and PP-2B caused dissociation of the tangles and the PHF; some of the PHF dissociated into straight protofilaments/subfilaments. Approximately 25% of the total tau was released from PHF on dephosphorylation by PP-2A1. These observations demonstrate that PHF II-tau is accessible to dephosphorylation by PP-2A1 and PP-2B, and dephosphorylation makes PHF dissociate, accessible to proteolysis by CANP, and biologically active in promoting the assembly of tubulin into microtubules.

摘要

微管相关蛋白tau在阿尔茨海默病患者大脑中异常过度磷酸化,这种形式是成对螺旋丝(PHF)的主要蛋白质亚基,而PHF是该疾病最显著的病变。在本研究中,研究了脑蛋白磷酸酶(PP)-2A1和PP-2B对难溶性PHF即PHF II-tau的去磷酸化作用,以及由此产生的生化、生物学和结构改变。两种磷酸酶都使PHF II-tau在Ser-199/Ser-202位点去磷酸化,并使其在Ser-396/Ser-404位点部分去磷酸化;此外,PP-2A1使PHF II-tau在Ser-46位点去磷酸化,PP-2B使PHF II-tau在Ser-235位点去磷酸化。经任何一种酶去磷酸化后,PHF II-tau的相对电泳迁移率增加。二价阳离子、锰和镁增加了PP-2A1和PP-2B对PHF II-tau的活性。PP-2B和PP-2A1的去磷酸化作用均降低了PHF II-tau对脑钙激活中性蛋白酶(CANP)蛋白水解的抗性。经PP-2A1和PP-2B去磷酸化后,PHF II-tau促进体外微管组装的能力得以恢复。由去磷酸化的PHF II-tau组装的微管在结构上与用作对照的牛tau组装的微管相同。PP-2A1和PP-2B的去磷酸化作用均导致缠结和PHF解离;一些PHF解离成直的原纤维/亚纤维。经PP-2A1去磷酸化后,约25%的总tau从PHF中释放出来。这些观察结果表明,PP-2A1和PP-2B可使PHF II-tau去磷酸化,去磷酸化使PHF解离,易于被CANP进行蛋白水解,并在促进微管蛋白组装成微管方面具有生物活性。

相似文献

1
Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B.蛋白磷酸酶2A和2B对阿尔茨海默病成对螺旋丝的去磷酸化作用
J Biol Chem. 1995 Mar 3;270(9):4854-60. doi: 10.1074/jbc.270.9.4854.
2
Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1.通过蛋白磷酸酶-2A、-2B和-1去磷酸化恢复阿尔茨海默病异常磷酸化tau蛋白的生物学活性。
Brain Res Mol Brain Res. 1996 Jun;38(2):200-8. doi: 10.1016/0169-328x(95)00316-k.
3
Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.蛋白磷酸酶2A对阿尔茨海默病异常磷酸化tau蛋白的去磷酸化作用
Neuroscience. 1994 Aug;61(4):765-72. doi: 10.1016/0306-4522(94)90400-6.
4
Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.神经原纤维变性及神经原纤维缠结形成的机制。
J Neural Transm Suppl. 1998;53:169-80. doi: 10.1007/978-3-7091-6467-9_15.
5
Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.参与阿尔茨海默病神经纤维变性的激酶、磷酸酶及tau位点。
Eur J Neurosci. 2007 Jan;25(1):59-68. doi: 10.1111/j.1460-9568.2006.05226.x.
6
Alzheimer paired helical filaments. Restoration of the biological activity by dephosphorylation.阿尔茨海默病配对螺旋丝。通过去磷酸化恢复生物活性。
FEBS Lett. 1994 Jul 25;349(1):104-8. doi: 10.1016/0014-5793(94)00650-4.
7
Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.神经原纤维变性机制及药物治疗方法
J Neural Transm Suppl. 2000;59:213-22. doi: 10.1007/978-3-7091-6781-6_22.
8
Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease.蛋白磷酸酶-1和-2C对微管相关蛋白tau的去磷酸化作用及其在阿尔茨海默病中的意义。
FEBS Lett. 1994 Mar 14;341(1):94-8. doi: 10.1016/0014-5793(94)80247-5.
9
Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.阿尔茨海默病中配对螺旋丝的泛素化与异常磷酸化
Mol Neurobiol. 1991;5(2-4):399-410. doi: 10.1007/BF02935561.
10
Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics.抗精神病药物对蛋白磷酸酶-2B(钙调神经磷酸酶)作用于阿尔茨海默病异常磷酸化tau蛋白活性的抑制作用。
Brain Res. 1996 Nov 25;741(1-2):95-102. doi: 10.1016/s0006-8993(96)00904-3.

引用本文的文献

1
The Role and Pathogenesis of Tau Protein in Alzheimer's Disease.Tau蛋白在阿尔茨海默病中的作用及发病机制
Biomolecules. 2025 Jun 5;15(6):824. doi: 10.3390/biom15060824.
2
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.神经退行性变中TDP - 43磷酸化的分子机制及后果
Mol Neurodegener. 2025 May 8;20(1):53. doi: 10.1186/s13024-025-00839-8.
3
Improving vulnerable Calbindin1 neurons in the ventral hippocampus rescues tau-induced impairment of episodic memory.改善腹侧海马体中易受损的钙结合蛋白1神经元可挽救tau蛋白诱导的情景记忆损伤。
Transl Neurodegener. 2025 Mar 4;14(1):12. doi: 10.1186/s40035-025-00473-w.
4
Updates in Alzheimer's disease: from basic research to diagnosis and therapies.阿尔茨海默病的最新研究进展:从基础研究到诊断和治疗。
Transl Neurodegener. 2024 Sep 4;13(1):45. doi: 10.1186/s40035-024-00432-x.
5
Expanding the horizons of targeted protein degradation: A non-small molecule perspective.拓展靶向蛋白质降解的视野:非小分子视角
Acta Pharm Sin B. 2024 Jun;14(6):2402-2427. doi: 10.1016/j.apsb.2024.01.010. Epub 2024 Jan 20.
6
Minding the Gap: Exploring Neuroinflammatory and Microglial Sex Differences in Alzheimer's Disease.关注差距:探索阿尔茨海默病中的神经炎症和小胶质细胞性别差异。
Int J Mol Sci. 2023 Dec 12;24(24):17377. doi: 10.3390/ijms242417377.
7
Serine/Threonine Protein Phosphatases 1 and 2A in Lung Endothelial Barrier Regulation.丝氨酸/苏氨酸蛋白磷酸酶1和2A在肺内皮屏障调节中的作用
Biomedicines. 2023 Jun 5;11(6):1638. doi: 10.3390/biomedicines11061638.
8
Light, Water, and Melatonin: The Synergistic Regulation of Phase Separation in Dementia.光、水和褪黑素:协同调节痴呆症中的相分离。
Int J Mol Sci. 2023 Mar 19;24(6):5835. doi: 10.3390/ijms24065835.
9
Homocysteine, Cognitive Functions, and Degenerative Dementias: State of the Art.同型半胱氨酸、认知功能与退行性痴呆:最新进展
Biomedicines. 2022 Oct 28;10(11):2741. doi: 10.3390/biomedicines10112741.
10
Perivascular spaces as a potential biomarker of Alzheimer's disease.血管周围间隙作为阿尔茨海默病的潜在生物标志物
Front Neurosci. 2022 Oct 18;16:1021131. doi: 10.3389/fnins.2022.1021131. eCollection 2022.